Mimotopes

Mimotopes is a specialized biotechnology company and contract research organization (CRO) focused on peptide synthesis and drug discovery services. Headquartered in Melbourne, Australia, the company was founded in 1988 as a spin-off from the CSIRO to commercialize the 'Multipin' peptide synthesis technology developed by Dr. Mario Geysen. Mimotopes provides a comprehensive suite of services, including custom peptide synthesis, the production of peptide libraries (PepSets), and epitope mapping for vaccine and antibody development. Their expertise supports researchers in pharmaceutical, biotech, and academic sectors globally, particularly in the fields of immunology and drug lead optimization. In 2022, Mimotopes was acquired by Biosynth, a global supplier of critical raw materials to the life sciences industry, further integrating its peptide capabilities into a broader manufacturing network.